Carcinomatous versus radiation-induced brachial plexus neuropathy in breast cancer
- PMID: 207407
- DOI: 10.1002/1097-0142(197806)41:6<2154::aid-cncr2820410612>3.0.co;2-#
Carcinomatous versus radiation-induced brachial plexus neuropathy in breast cancer
Abstract
A retrospective study was performed of 18 women in whom ipsilateral brachial plexus neuropathy developed after treatment for carcinoma of the breast. In the absence of metastatic tumor elsewhere, the only distinguishing feature between carcinomatous neuropathy and radiation-induced neuropathy was the symptom-free interval after mastectomy and radiation therapy. Women with an interval of less than a year have radiation-induced neuropathy. Brachial plexus exploration in difficult diagnostic situations will permit early treatment and avoid debilitating loss of function. Brachial plexus exploration for biopsy is safe and free of complications if performed carefully. Treatment of carcinomatous neuropathy is most likely to succeed if the tumor is hormonally sensitive, but radiotherapy may also be effective. Treatment of radiation-induced neuropathy remains largely ineffective.
Similar articles
-
[Plexus neuropathy: tumor infiltration or radiation damage].Rofo. 1990 Jun;152(6):662-6. doi: 10.1055/s-2008-1046944. Rofo. 1990. PMID: 2163070 German.
-
Radiation-induced brachial plexus neuropathy - aetiopathogenesis, risk factors, differential diagnostics, symptoms and treatment.Folia Neuropathol. 2007;45(1):26-30. Folia Neuropathol. 2007. PMID: 17357008 Review.
-
Audit of brachial plexus neuropathy following radiotherapy.Clin Oncol (R Coll Radiol). 1995;7(4):236. doi: 10.1016/s0936-6555(05)80607-7. Clin Oncol (R Coll Radiol). 1995. PMID: 8845319 No abstract available.
-
A multidisciplinary approach for the treatment of metastatic brachial plexus neuropathy from breast cancer: neurosurgical, plastic, and radiotherapeutic.Neurochirurgia (Stuttg). 1983 May;26(3):86-8. doi: 10.1055/s-2008-1053617. Neurochirurgia (Stuttg). 1983. PMID: 6308487
-
Diagnosis and management of brachial plexus lesions in cancer patients.Oncology (Williston Park). 1995 Aug;9(8):756-60; discussion 765. Oncology (Williston Park). 1995. PMID: 7577375 Review.
Cited by
-
[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management.Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):179-88. doi: 10.1007/s00259-003-1348-1. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129699 Clinical Trial.
-
Metastases to the peripheral nervous system.J Neurooncol. 2005 Oct;75(1):101-10. doi: 10.1007/s11060-004-8102-9. J Neurooncol. 2005. PMID: 16215820 Review.
-
Metastatic Brachial Plexopathy with Brain and Spinal Metastasis in a Case of Recurrent Breast Carcinoma Demonstrated on 18F-FDG PET/CT.Indian J Nucl Med. 2017 Apr-Jun;32(2):118-121. doi: 10.4103/0972-3919.202252. Indian J Nucl Med. 2017. PMID: 28533639 Free PMC article.
-
Characteristics of metastatic brachial plexopathy in patients with breast cancer.Support Care Cancer. 2020 Apr;28(4):1913-1918. doi: 10.1007/s00520-019-04997-6. Epub 2019 Jul 30. Support Care Cancer. 2020. PMID: 31363905
-
Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients.Br J Cancer. 1999 Feb;79(3-4):478-82. doi: 10.1038/sj.bjc.6690074. Br J Cancer. 1999. PMID: 10027316 Free PMC article. Clinical Trial.